Cardiopulmonary Collaboration in Respiratory Care: Shifting the Paradigm
Bibliographic record
Abstract
In recent years, the management of chronic obstructive pulmonary disease (COPD) has evolved from a symptom driven focus to prioritizing the reduction of exacerbations, with a view to preventing morbidity and mortality. This treatment landscape continues to evolve, with biologic therapies on the horizon that promise to substantially alter the current paradigm centred on inhaled therapies. While other jurisdictions have approved dupilumab and mepolizumab as add-on therapies to prevent COPD exacerbations, these options are not yet approved for use in Canada. Regardless of regulatory status, the foundation of COPD therapy remains the same: triple inhaled therapy, combined with inhaled corticosteroids, long-acting anti-muscarinic agents, and long‑acting beta-agonists. At the time of enrolment in the studies, single inhaler triple therapy (SITT) was not yet the standard of care; however, the majority of enrolled patients (over 98%) were receiving all three components. While multiple inhaler triple therapy was permitted, both studies demonstrated a statistically significant reduction in COPD exacerbations. Biologics are intended as an add-on to baseline therapy, yet many patients remain undertreated and lack access to SITT. Our Canadian COPD guidelines have emphasized a clear preference for SITT, advocating for its rapid initiation in highly symptomatic patients, and those at increased risk of exacerbations. SITT has been demonstrated to reduce exacerbations and mortality, contributing to a reduction in hospitalizations and emergency department visits. Nevertheless, many patients remain on inadequate therapy and continue to face an elevated risk of exacerbations, thus predisposing them to increased mortality. In both the ETHOS and IMPACT trials, the most commonly adjudicated causes of death were cardiopulmonary in nature. Single inhaler therapy has been shown to be safe, effective, and economical. The number needed to treat (NNT) to prevent a moderate or severe COPD exacerbation is 1:4, while the number needed to harm (NNH) for pneumonia is 1:33. Despite this favourable profile, there appears to be hesitancy regarding initiation of therapy. Whether this stems from regulatory barriers regarding access to medication, hesitancies based on risk perception pertaining to pneumonia or other adverse events, or gaps in knowledge, this is a situation which deserves urgent attention, in light of the simplicity and effectiveness of this intervention.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.003 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.001 | 0.001 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.001 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".